(Q37085101)

18 August 2017

1 reference

title

Vascular cognitive impairment: current concepts and clinical developments (English)

1 reference

18 August 2017

main subject

cognitive dysfunction

1 reference

2

Kenneth Rockwood

1 reference

18 August 2017

Paige Moorhouse

1

1 reference

18 August 2017

publication date

1 March 2008

1 reference

18 August 2017

number of pages

10

1 reference

inferred from page(s)

published in

Lancet Neurology

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

246-255

1 reference

Vascular cognitive impairment.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Prevalence and outcomes of vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Multi-infarct dementia. A cause of mental deterioration in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Vascular dementia is overdiagnosed

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Mild cognitive impairment as a diagnostic entity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Progression of impairment in patients with vascular cognitive impairment without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Frequency of cognitive impairment without dementia in patients with stroke: a two-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Cognitive impairment and dementia 20 months after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Poststroke dementia : clinical features and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Poststroke dementia: incidence and relationship to prestroke cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Dementia after stroke: the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Editorial comment--dementia after stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Short-term evolution as a marker of vascular dementia versus Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Neuropathological assessment of the lesions of significance in vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Subcortical ischaemic vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Differentiation of vascular dementia from AD on neuropsychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Modern concept of vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Neuropsychological performance in Alzheimer's disease and vascular dementia: comparisons in a memory clinic population.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Differentiation of vascular dementia from AD on neuropsychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

A clinico-pathological study of heart and brain lesions in vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Clinicopathological Validation Study of Four Sets of Clinical Criteria for Vascular Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Cognitive impairment of acute onset in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) study: occurrence, correlates, and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

1 reference

7 January 2021

Dementias that present with and without posterior cortical features: an important clinical distinction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

The validity of brief screening cognitive instruments in the diagnosis of cognitive impairment and dementia after first-ever stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Validation of clinical criteria for possible vascular dementia in the oldest-old

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

MRI and CT in the diagnosis of vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

White matter damage on diffusion tensor imaging correlates with age-related cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Towards defining the neuropathological substrates of vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Vascular Dementia in a Population-Based Autopsy Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Correlation between intrathecal sulfatide and TNF-alpha levels in patients with vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Index variables for studying outcomes in vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

The pattern of neuropsychological deficits in Vascular Cognitive Impairment-No Dementia (Vascular CIND).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Vascular mild cognitive impairment is highly prevalent after lacunar stroke but does not increase over time: a 2-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Evolution of cognitive impairment after stroke and risk factors for delayed progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Donepezil in vascular dementia: combined analysis of two large-scale clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Cardiovascular risk factors and cognitive decline in middle-aged adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Association of diabetes mellitus and dementia: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Emerging therapies for vascular dementia and vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Physical activity and white matter lesion progression: assessment using MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Blood vessel function and cognition in elderly patients with atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Cross-sectional correlates of increased aortic stiffness in the community: the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: the Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

Fluency and memory differences between ischemic vascular dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970040-1

7 January 2021

10.1016/S1474-4422(08)70040-1

Identifiers

DOI

1 reference

18 August 2017

1 reference